Company / Total Assets
FENNEC PHARMACEUTICALS INC. Total Assets History
FY2014-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$70.6M
FY2025
5-year range
$14.1M / $70.6M
FY2021-FY2025
Trend
+57.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Total Assets has increased for 4 consecutive years, from $14M in FY2019 to $71M in FY2025.
Based on SEC 10-K filings.
$71M in FY2025 with a 10-year CAGR of +52.8%.
Improved from $27M to $71M over the past 2 years.
Total Assets over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- +52.8%
Key checks
Key Insights
- FENNEC PHARMACEUTICALS INC.'s total assets has grown for 4 consecutive years.
- In FY2025, total assets increased 57.0% year-over-year.
- Lowest total assets in the period was in FY2015.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $70.6M | +57.0% |
| FY2024 | $44.9M | +67.3% |
| FY2023 | $26.9M | +19.9% |
| FY2021 | $22.4M | +58.4% |
| FY2019 | $14.1M | -38.4% |
| FY2018 | $22.9M | -19.2% |
| FY2017 | $28.4M | +615.0% |
| FY2016 | $4.0M | +289.8% |
| FY2015 | $1.0M | -57.0% |
| FY2014 | $2.4M | +35.4% |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 24, 2026